CERE
Cerevel Therapeutics Holdings, Inc.
CFO Susan Altschuller sold $572K of Cerevel Therapeutics Holdings, Inc.
Sold$571,972
$41.42Price
13,808Shares
−45%Stake
What CERE did after the filing
- The stock from Thu, Dec 21 close, $41.39
- +0.7%
- S&P 500, same days
- +4.5%
Measured over 30 trading days, to the Feb 6 close.
Traded Wed, Dec 20. Filed Thu, Dec 21, 3:12 PM ET, during the session. Returns use the Dec 21 close and the Feb 6 close. Not investment advice.